Replies to post #14886 on ANI Pharmaceuticals (ANIP)

[silvr_surfr]

You called it JTFM. The 10 Q is out and I am not seeing any updates on the CGON litigation. CGON did not provide an update either in their report. What is included in the 10Q is the original transfer agreement with Cold Genesys. I don't see the language you were hoping for to extend the patent term. However, there is some very interesting language around us retaining a 19.99% equity stake in the company regardless. That seems like a bigger deal (I wonder if the investors in the various rounds were made aware of this).

I guess the court will figure it out. It deserves a question on the conference call today, but it will probably not happen.